PAX8 and cyclic hematopoiesis: We extensively functionally characterized two selected mutations G41V and D94N and demonstrated their significant impairing effects on the binding or activating abilities of PAX8 at the promoters of the target genes TG and TPO, establishing their pathogenic role in the development of CH from thyroid dysgenesis.